Related Experiment Video
Updated: Feb 22, 2026

Assessment of Cardiac Morphological and Functional Changes in Mouse Model of Transverse Aortic Constriction by Echocardiographic Imaging
Published on: June 21, 2016
Predictors of Prognosis in Light-Chain Amyloidosis and Chronological Changes in Cardiac Morphology and Function
Masashi Amano1, Chisato Izumi1, Shunsuke Nishimura1
1Department of Cardiology, Tenri Hospital, Tenri, Japan.
Insights
Prognosis for cardiac AL amyloidosis remains poor, with diastolic wall strain (DWS) identified as a key predictor of death. Worsening DWS and cardiac changes indicate a grim outlook for affected patients.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Amyloidosis Research
Background:
- Cardiac AL amyloidosis presents a significant mortality risk despite advancements in treatment.
- Limited data exists on prognostic indicators and temporal changes in cardiac structure and function.
Purpose of the Study:
- To evaluate prognosis and identify predictors of mortality in cardiac AL amyloidosis.
- To assess longitudinal changes in cardiac morphology and function.
Main Methods:
- Retrospective analysis of 36 consecutive patients with cardiac AL amyloidosis.
- Evaluation of prognostic factors including left ventricular wall thickness and diastolic wall strain (DWS).
- Assessment of chronological changes in cardiac dimensions and function over the follow-up period.
Main Results:
- The median survival time was 0.85 years; 3-year death-free rates were 26% (all-cause) and 36% (cardiac).
- Female sex and higher DWS were independent predictors of all-cause mortality.
- A DWS cutoff of 0.189 predicted 1-year all-cause death with 78% sensitivity and 72% specificity (AUC=0.726).
- Patients who died within 1 year showed decreased left ventricular size and stroke volume, and worsening DWS compared to survivors.
- Progressive diastolic dysfunction and left ventricular cavity narrowing were observed in patients with poor prognosis.
Conclusions:
- Cardiac AL amyloidosis carries a poor prognosis.
- Diastolic wall strain (DWS) is a significant predictor of outcomes in cardiac AL amyloidosis.
- Short-term follow-up reveals detrimental cardiac remodeling and functional decline in non-survivors.
Abstract:
Immune light-chain (AL) amyloidosis with cardiac involvement is associated with a high mortality despite improved therapeutic regimens, but there are few reports on prognostic predictors and chronological changes in cardiac morphology and function. Prognosis and its predictors were evaluated in 36 consecutive patients with cardiac AL amyloidosis. Chronological changes in cardiac morphology and function were also evaluated. The median follow-up period was 0.95 years. The median survival time and the 3-year death-free rate after diagnosis in all-cause and cardiac deaths were 0.85 and 1.06 years and 26% and 36%, respectively. Differences in the median survival time due to left ventricular (LV) wall thickness at diagnosis were not evident. Being female and diastolic wall strain (DWS), as a measure of diastolic stiffness, were independent predictors of all-cause death in the multivariable analysis. The receiver operating characteristic analysis revealed that a DWS cut-off value of 0.189 had a sensitivity of 78% and a specificity of 72% for predicting all-cause death within 1 year after diagnosis (area under the curve = 0.726). The LV size and the stroke volume decreased and DWS worsened during the short-term follow-up period in patients who died within 1 year compared with patients who were alive after 1 year. The prognosis for patients with cardiac AL amyloidosis was poor, and DWS may be a significant predictor of prognosis. Narrowing of the LV cavity and progressive diastolic dysfunction were evident in patients with a poor prognosis.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care